Literature DB >> 361224

Phase I clinical evaluation of anguidine.

W K Murphy, M A Burgess, M Valdivieso, R B Livingston, G P Bodey, E J Freireich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 361224

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

1.  Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins in the indoor environment.

Authors:  T L Brasel; J M Martin; C G Carriker; S C Wilson; D C Straus
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

2.  Combined Exposure to Multiple Mycotoxins: An Example of Using a Tiered Approach in a Mixture Risk Assessment.

Authors:  Annick D van den Brand; Bas G H Bokkers; Jan Dirk Te Biesebeek; Marcel J B Mengelers
Journal:  Toxins (Basel)       Date:  2022-04-26       Impact factor: 5.075

3.  Anguidine potentiates cis-platinum in human brain tumor cells.

Authors:  R A Hromas; W K Yung
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

4.  Mycotoxin detection in human samples from patients exposed to environmental molds.

Authors:  Dennis G Hooper; Vincent E Bolton; Frederick T Guilford; David C Straus
Journal:  Int J Mol Sci       Date:  2009-04-01       Impact factor: 6.208
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.